95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.03%
Negative revenue growth while OR stands at 39.75%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
5.03%
Gross profit growth under 50% of OR's 39.75%. Michael Burry would be concerned about a severe competitive disadvantage.
5.03%
EBIT growth below 50% of OR's 775.00%. Michael Burry would suspect deeper competitive or cost structure issues.
5.03%
Operating income growth under 50% of OR's 775.00%. Michael Burry would be concerned about deeper cost or sales issues.
-5.02%
Negative net income growth while OR stands at 570.81%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-7.14%
Negative EPS growth while OR is at 576.19%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-7.14%
Negative diluted EPS growth while OR is at 544.44%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend reduction while OR stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-5.30%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-962.45%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
265.57%
10Y CAGR of 265.57% while OR is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
40.18%
5Y CAGR of 40.18% while OR is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
-37.68%
Negative 3Y CAGR while OR stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
679.42%
Positive long-term OCF/share growth while OR is negative. John Neff would see a structural advantage in sustained cash generation.
42.85%
Positive OCF/share growth while OR is negative. John Neff might see a comparative advantage in operational cash viability.
-48.13%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
329.48%
Net income/share CAGR above 1.5x OR's 179.19% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
2.22%
Below 50% of OR's 179.19%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-67.99%
Negative 3Y CAGR while OR is 179.19%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
1148.91%
Equity/share CAGR of 1148.91% while OR is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
129.90%
Equity/share CAGR of 129.90% while OR is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
52.76%
Equity/share CAGR of 52.76% while OR is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-28.08%
Firm’s AR is declining while OR shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
13.35%
Asset growth well under 50% of OR's 300.19%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
22.01%
Under 50% of OR's 258.14%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-19.88%
We’re deleveraging while OR stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-3.79%
We cut SG&A while OR invests at 24.80%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.